Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,885,526
-
Share change
-
+126,174
-
Total reported value
-
$15,033,000
-
Price per share
-
$5.21
-
Number of holders
-
12
-
Value change
-
+$637,506
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q3 2017
As of 30 Sep 2017,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,885,526 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Lyon Street Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, Tower Research Capital LLC (TRC), UBS Group AG, and MEEDER ASSET MANAGEMENT INC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.